Navigation Links
Abiant, Inc. Announces Close on Investment Round
Date:10/1/2007

CHICAGO, Oct. 1 /PRNewswire/ -- Abiant, Inc., an Illinois based company specializing advanced bio-imaging to accelerate and improve drug development and disease diagnosis, announces the successful closing of a $600,000 private placement. Lead investor Heartland Angels, an angel network specializing in early-stage technology, syndicated the round with Kettering Medical Center and other participants. Abiant has developed partnerships with large pharmaceutical companies and with academic collaborators. The company has obtained an exclusive license from New York University School of Medicine to image processing technology that has enabled the early and accurate identification of dementias.

Ed Maier, owner of the Maier Consulting Group and a former Senior Partner with Arthur Andersen, and Rick Mace, Vice President, Clinical Services Division of Kettering Medical Center, have joined Abiant's Board of Directors as part of this Offering. We are excited about supporting a technology that will change the way we monitor CNS drug effects in the clinical testing process", said Ron Kirschner, M.D., President of Heartland Angels. Dawn Matthews, President and CEO of Abiant, said "With this financing, we are adding two valuable strategic partners and the resources to expand the application of our imaging technology. We are eager to continue the progress created by the dedication and shared vision of our team, customers, and stakeholders." O.B. Parrish, Chairman of Abiant's Board, added "This financing provides Abiant with the opportunity to grow and capitalize on its technology".

About Abiant, Inc.

Abiant, Inc. uses proprietary image analysis methods and software to provide a sensitive biomarker of drug effects and disease progression. The imaging information, which includes biochemical, functional, and structural measurements, can be used to accelerate or reduce risk of decision making in both drug development and disease treatment. The Company's focus areas include the central nervous system, oncology, and inflammation. Further information can be found at http://www.abiant-imaging.com.

Forward Looking Statements

This press release may contain "forward-looking" statements identified by words such as "will," "continue," "grow," and "capitalize". There are a number of important factors that could cause Abiant's results to differ materially from those indicated by these forward-looking statements.


'/>"/>
SOURCE Abiant, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for ... June 2018 in San Francisco, CA. The Summit brings together current and former FDA ... board directors and government officials from around the world to address key issues in ...
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading provider ... nationwide oncology Clinical Nurse Educator (CNE) network, which will launch ... for communication among health care professionals to enhance the patient ... office staff, and other health care professionals to help women ... cancer. ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
Breaking Biology News(10 mins):